Suven to present 5 posters at Alzheimer's conference in London
SUVEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Suven Life Sciences will present five scientific posters at AAIC 2026 in London from July 12 to 15. Key presentations include updates from its global Phase-3 Masupirdine study for agitation in Alzheimer's Dementia and the Usmarapride Phase-2 program for cognitive disorders. Other posters cover early-stage CNS compounds targeting Alzheimer's, schizophrenia, and neurodegenerative disorders. The company will also engage with researchers and explore strategic partnering opportunities at its exhibit booth.
Showcases pipeline progress to global research community; may attract partnership interest for clinical-stage CNS assets. No direct financial impact.